Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities
Healthcare - Press Releases
- 1085 Press Releases ยท
- RSS
Published on Fri 11 Apr 2025 5:44:19 UTC
JACKSONVILLE, Ark., April 10, 2025 /PRNewswire/ -- Jacksonville Medical Care ("JMC") and Cabot Medical Care ("CMC") are providing notice of a recent data security incident that may have involved personal and/or protected health information. JMC and CMC take the privacy and security of all information within their possession very seriously. JMC and CMC have sent notice of this incident to potentially affected individuals and provided resources to assist them.
Published on Mon 7 Apr 2025 6:21:17 UTC
PRINCETON, N.J., April 6, 2025 /PRNewswire/ -- Luye Pharma Group today announced that ERZOFRI (paliperidone palmitate) extended-release injectable suspension is now available for commercial sale in the U.S. forthe treatment of adults with schizophrenia and as a monotherapy or adjunct therapy for the treatment of adults with schizoaffective disorder.
Published on Mon 7 Apr 2025 6:21:15 UTC
, 7 2025 . /PRNewswire/ -- George Clinical, (CRO), , EmeraldClinical Trials. , , CRO, , , , 20 .
Published on Mon 7 Apr 2025 6:21:12 UTC
Nowa nazwa odzwierciedla rozwj firmy oraz jej wizj wspierania przejrzystoci i pewnoci w globalnych badaniach klinicznych.
Published on Mon 7 Apr 2025 6:21:09 UTC
Le nouveau nom reflte la croissance de l'entreprise et sa volont d'apporter certitude et transparence aux essais cliniques mondiaux.
Published on Mon 7 Apr 2025 6:21:04 UTC
El nuevo nombre refleja el crecimiento de la empresa y su visin de ayudar a brindar certeza y transparencia a los ensayos clnicos globales.
Published on Mon 7 Apr 2025 6:21:01 UTC
Der neue Name spiegelt das Wachstum des Unternehmens und seine Vision wider, Sicherheit und Transparenz bei globalen klinischen Studien zu schaffen
Published on Mon 7 Apr 2025 6:20:59 UTC
Nov nzev odr rst spolenosti a vizi pomhat vnet jistotu a transparentnost do globlnch klinickch studi
Published on Mon 7 Apr 2025 6:20:56 UTC
- ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases
Published on Mon 7 Apr 2025 6:20:50 UTC
World Health Day Statement by Education Cannot Wait Director Yasmine Sherif
Published on Mon 7 Apr 2025 6:18:49 UTC
- ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases
Published on Mon 7 Apr 2025 6:18:13 UTC
SHANGHAI, April 7, 2025 /PRNewswire/ -- DualityBio announced today that Dr. Hua Mu has joined the company as Global Chief Medical Officer (CMO). In this role, Dr. Mu will oversee the strategic planning, meticulous design, efficient execution, and comprehensiveregulatory compliance of the company's global clinical development efforts, ensuring adherence to the most stringent international regulatory standards.
Published on Mon 7 Apr 2025 6:18:12 UTC
NUEVA YORK, 7 de abril de 2025 /PRNewswire/ -- Ypsomed y Sidekick Health lanzan una solucin de salud digital integrada para ofrecer un mejor apoyo a las personas con obesidad. Los autoinyectores de Ypsomed se integran a la perfeccin con la aplicacin de salud digital y apoyo para enfermedades crnicas de Sidekick para ayudar a los pacientes que usan terapias inyectables basadas en GLP-1 a gestionar su tratamiento de forma ms eficaz.
Published on Mon 7 Apr 2025 6:18:09 UTC
NEW YORK, April 7, 2025 /PRNewswire/ -- Ypsomedand Sidekick Health are launching an integrated digital health solution to better support people with obesity. Ypsomed's autoinjectors seamlessly integrate into Sidekick's digital health and chronic condition support app to help patients using GLP-1-based injectable therapies manage their treatment more effectively.
Published on Mon 7 Apr 2025 6:18:07 UTC
NEW YORK, April 7, 2025 /PRNewswire/ -- Ypsomed and Sidekick Health are launching an integrated digital health solution to better support people with obesity. Ypsomed's autoinjectors seamlessly integrate into Sidekick's digital health and chronic condition support app to help patients using GLP-1-based injectable therapies manage their treatment more effectively.
Published on Mon 7 Apr 2025 6:18:04 UTC
NEW YORK, 7. April 2025 /PRNewswire/ -- Ypsomed und Sidekick Health lancieren eine integrierte digitale Gesundheitslsung zur besseren Untersttzung von Menschen mit Adipositas. Die Autoinjektoren von Ypsomed lassen sich nahtlos in die digitale Gesundheits-App von Sidekick integrieren, um Patienten, die GLP-1-basierte Injektionstherapien anwenden, dabei zu helfen, ihre Behandlung effektiver zu verwalten.
Published on Mon 7 Apr 2025 6:18:01 UTC
NEW YORK, 7 avril 2025 /PRNewswire/ -- Ypsomed et Sidekick Health lancent une solution de sant numrique intgre pour mieux soutenir les personnes souffrant d'obsit. Les auto-injecteurs d'Ypsomed s'intgrent parfaitement l'application de sant numrique et de soutien aux maladies chroniques de Sidekick pour aider les patients utilisant des thrapies injectables base de GLP-1 grer leur traitement plus efficacement.
Published on Mon 7 Apr 2025 6:17:59 UTC
SHANGHAI, April 7, 2025 /PRNewswire/ -- DualityBio announced today that Dr. Hua Mu has joined the company as Global Chief Medical Officer (CMO). In this role, Dr. Mu will oversee the strategic planning, meticulous design, efficient execution, and comprehensive regulatory compliance of the company's global clinical development efforts, ensuring adherence to the most stringent international regulatory standards.
Published on Mon 7 Apr 2025 6:14:16 UTC
LOS ANGELES, April 7, 2025 /PRNewswire/ -- In observance of World Health Day on April 7, Scientology Network presents a marathon television event featuring the Drug-Free World movement to educate people on the true dangers of drugs.
Published on Mon 7 Apr 2025 6:10:41 UTC
Philips CT 3500, a scalable, adaptable, and durable imaging solution, improves efficiency and care quality, optimizes patient and user experience, and enhances clinical outcomes and operational efficiency.
Published on Wed 2 Apr 2025 10:48:13 UTC
COLD SPRING HARBOR, N.Y., April 2, 2025 /PRNewswire/ -- Pancreatic cancer is projected to become the second-deadliest cancer by 2030. By the time it's diagnosed, it's often difficult to treat. So, for both individual patients and the general population, fighting pancreatic cancer can feel like a race against time. Cold Spring Harbor Laboratory (CSHL) Professor and Cancer Center Director David Tuvesonoffers a telling analogy:
Published on Wed 2 Apr 2025 10:48:09 UTC
Hanmi Pharm Begins Local Sales of Urological Product 'Aditams' in Mexico with Partner 'Laboratorios Silanes'
Published on Wed 2 Apr 2025 10:48:03 UTC
HONG KONG and SHANGHAI, April 2, 2025 /PRNewswire/ -- On 1 April 2025, Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group") held its 2024 annual results presentation in Shanghai. The results presentation was attended by Guo Guangchang, Chairman of Fosun International, Wang Qunbin, Co-Chairman of Fosun International, Chen Qiyu and Xu Xiaoliang, Co-CEOs of Fosun International, Gong Ping, CFO of Fosun International, and a number of institutional investors and analysts.
Published on Wed 2 Apr 2025 10:48:02 UTC
LONDON, April 2, 2025 /PRNewswire/ -- Accord Healthcare Limited (Accord) is pleased to announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Denosumab, including its branded formulations Osvyrti and Jubereq, across its autoimmune and oncology therapy areas.
Published on Wed 2 Apr 2025 10:47:59 UTC
LUND, Sweden, April 2, 2025 /PRNewswire/ -- Immunovia AB (publ) today announced that the Annual Report for 2024 has been published.
Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities